RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/C6EF8005C5BF84F0C9411365D1C016C46B7885B435CBDC45185A3F19DC681545BA15DEDAFC14DBF266073FA65F86D1A4http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C6EF8005C5BF84F0C9411365D1C016C46B7885B435CBDC45185A3F19DC681545BA15DEDAFC14DBF266073FA65F86D1A4http://www.w3.org/2000/01/rdf-schema#comment"Observational study of gene-disease association gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator); The risk of gastrointestinal bleeding during acenocoumarol therapy in carriers of any of the studied polymorphisms is severely increased with exposure to weekly doses of acenocoumarol higher than 15 mg or the use of amiodarone or aspirin."xsd:string
http://purl.uniprot.org/uniprot/#_C173567CBC5580E400C17532EFD1AA434D1B1C7B9EA6BEDA4099C747B4D26E7B813449FC944568E2487DD8A9B2E0C083http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/C6EF8005C5BF84F0C9411365D1C016C46B7885B435CBDC45185A3F19DC681545BA15DEDAFC14DBF266073FA65F86D1A4
http://purl.uniprot.org/uniprot/Q9BQB6http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/C6EF8005C5BF84F0C9411365D1C016C46B7885B435CBDC45185A3F19DC681545BA15DEDAFC14DBF266073FA65F86D1A4
http://purl.uniprot.org/uniprot/#_Q9BQB6-mappedCitation-18950464http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/C6EF8005C5BF84F0C9411365D1C016C46B7885B435CBDC45185A3F19DC681545BA15DEDAFC14DBF266073FA65F86D1A4